UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039047
Receipt number R000044528
Scientific Title Febrile Seizure Owing to Premature Blood-Brain Barrier Integrity: A New Mechanism
Date of disclosure of the study information 2020/01/06
Last modified on 2023/07/07 11:05:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Febrile Seizure Owing to Premature Blood-Brain Barrier Integrity: A New Mechanism

Acronym

Febrile Seizure: A New Mechanism

Scientific Title

Febrile Seizure Owing to Premature Blood-Brain Barrier Integrity: A New Mechanism

Scientific Title:Acronym

Febrile Seizure: A New Mechanism

Region

Japan


Condition

Condition

Febrile seizure

Classification by specialty

Neurology Pediatrics Emergency medicine
Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the mechanism of febrile seizure

Basic objectives2

Others

Basic objectives -Others

Blood-brain barrier integrity in children with febrile seizures

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood-brain barrier integrity in children with febrile seizures

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

10 years-old >=

Gender

Male and Female

Key inclusion criteria

Children with febrile seizures

Key exclusion criteria

Contraindication for MRI

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Yuto
Middle name
Last name Uchida

Organization

Toyokawa City Hospital

Division name

Neurology

Zip code

442-08571

Address

23 Noji Yawata Toyokawa

TEL

0533-86-1111

Email

uchidayuto0720@yahoo.co.jp


Public contact

Name of contact person

1st name Shinobu
Middle name
Last name Kito

Organization

Toyokawa City Hospital

Division name

Neurology

Zip code

442-08571

Address

23 Noji Yawata Toyokawa

TEL

0533-86-1111

Homepage URL


Email

kitomrn@toyokawa-ch-aichi.jp


Sponsor or person

Institute

Toyokawa City Hospital

Institute

Department

Personal name



Funding Source

Organization

Toyokawa City Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toyokawa City Hospital

Address

23 Noji Yawata Toyokawa

Tel

0533-86-1111

Email

uchidayuto0720@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 01 Month 03 Day

Date of IRB

2019 Year 12 Month 13 Day

Anticipated trial start date

2020 Year 01 Month 06 Day

Last follow-up date

2024 Year 01 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

N.A.


Management information

Registered date

2020 Year 01 Month 03 Day

Last modified on

2023 Year 07 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044528


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name